Company Overview and News
The battery pack in Tesla's Semi will cost the same as the entire truck: $180K. Tesla is thus unlikely to turn a profit selling tractor trucks.
Gasoline prices are up 25% over the last year, but U.S. pickup truck sales are up 3% in 1Q 2018. What gives? And going forward?
Last April, I pondered whether Ford Motor Company (NYSE:F) could afford to buy Tesla Inc (NASDAQ:TSLA). For the sake of Ford stock, here’s why I think Ford absolutely should buy Tesla.
Fantasy and reality now find themselves at cross purposes at Tesla Inc (NASDAQ:TSLA). The Palo Alto-based company once impressed investors and consumers alike with power generation technology could change the way the world generates and consumes energy. However, the costs of bringing many of CEO Elon Musk’s goals to reality has come at a cost. Now, with Tesla’s cash crunch, it must prioritize company stability over bringing concepts to market.
Roth IRAs are going to be the most fun to write about of any of the postings in this series. There are just so many benefits to Roth accounts that they are fun to think about. It isn't just about taxes, but they're good place to start.
Among full-size pickup trucks powered by gasoline, the Ford Motor Co. (NYSE: F) F-150 is the reigning champion, with U.S. Environmental Protection Agency (EPA) fuel-economy ratings of 20 miles per gallon in city driving, 26 mpg in highway driving and a combined rating of 22 mpg. General Motors Co. (NYSE: GM) and Fiat Chrysler Automobiles N.V. (NYSE: FCAU) are taking dead aim at those numbers with major improvements to their 2019 full-size pickups.
Although it is one of the most recognized technology names, Tesla Inc (NASDAQ:TSLA) has been recently making news for the wrong reasons. Primarily, investors are losing confidence that CEO Elon Musk has the right mentality to keep Tesla moving forward. As a result, TSLA stock took a beating.
The company is the leading vendor of what are called 'cloud native tools" to help users rapidly build applications that run in all the different flavors of the cloud.
Tesla wants to build a plant (battery & assembly) in China in order to cut some costs.
The European Automobile Manufacturers Association (ACEA) reported Thursday that new vehicle registrations in the European Union (EU) jumped 9.6% in April compared with new registrations in April of 2017. New registrations for the month totaled 1.31 million units.
After a fire took a supplier of parts for Ford’s (NYSE: F) F-150 offline and worried investors that the company’s No.1 selling vehicle by far would face falling inventories, the company announced that production is coming back online
Self-driving cars are on the way — and investors are looking to profit. One popular choice in self-driving car stocks has been Tesla Inc (NASDAQ:TSLA), a potential play on the shift to both electric automobiles and autonomous driving. But with TSLA stock looking a bit shaky at the moment, investors might benefit from looking toward less well-covered — and less volatile — autonomous driving car stocks.
The market hasn’t repeated on its 2017 success in 2018. But the trend-line is still up. The S&P 500 is up about 2.5% year-to-date.
23h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
23h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET